Form 4: Revolution Medicines Director Sells Shares
Insider Transaction (Form 4)
Lorence H. Kim, a Director of Revolution Medicines, Inc., sold 17,090 shares of common stock on September 8, 2026.
Summary
- Open-market sale: disposed of 706 Common Stock at $206.60 ($145,863) on September 8, 2026; holds 16,384 after (Indirect).
- Open-market sale: disposed of 999 Common Stock at $207.33 ($207,125) on September 8, 2026; holds 15,385 after (Indirect).
- Open-market sale: disposed of 3,587 Common Stock at $208.55 ($748,081) on September 8, 2026; holds 11,798 after (Indirect).
- Open-market sale: disposed of 2,853 Common Stock at $209.56 ($597,875) on September 8, 2026; holds 8,945 after (Indirect).
- Open-market sale: disposed of 4,730 Common Stock at $210.50 ($995,678) on September 8, 2026; holds 4,215 after (Indirect).
- Open-market sale: disposed of 3,844 Common Stock at $211.36 ($812,463) on September 8, 2026; holds 371 after (Indirect).
- Open-market sale: disposed of 371 Common Stock at $212.27 ($78,752) on September 8, 2026 (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $3,585,837 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Lorence H. Kim — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-08 | Open-market sale | Common Stock | 706 | $207 | $145.9K | 16,384 |
| 2026-09-08 | Open-market sale | Common Stock | 999 | $207 | $207.1K | 15,385 |
| 2026-09-08 | Open-market sale | Common Stock | 3,587 | $209 | $748.1K | 11,798 |
| 2026-09-08 | Open-market sale | Common Stock | 2,853 | $210 | $597.9K | 8,945 |
| 2026-09-08 | Open-market sale | Common Stock | 4,730 | $211 | $995.7K | 4,215 |
| 2026-09-08 | Open-market sale | Common Stock | 3,844 | $211 | $812.5K | 371 |
| 2026-09-08 | Open-market sale | Common Stock | 371 | $212 | $78.8K | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-08 | Open-market sale (706 shares) |
| 2026-09-08 | Open-market sale (999 shares) |
| 2026-09-08 | Open-market sale (3,587 shares) |
| 2026-09-08 | Open-market sale (2,853 shares) |
| 2026-09-08 | Open-market sale (4,730 shares) |
| 2026-09-08 | Open-market sale (3,844 shares) |
| 2026-09-08 | Open-market sale (371 shares) |
Keywords
insider transaction, Form 4, RVMD, Revolution Medicines, Inc., bearish, Lorence H. Kim
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.